Which trial do we need? Management of elderly, fragile, fully vaccinated patients hospitalized for SARS-CoV-2 infection
Clin Microbiol Infect
.
2023 Apr;29(4):419-421.
doi: 10.1016/j.cmi.2023.01.006.
Epub 2023 Jan 12.
Authors
Marius Trøseid
1
,
Jose R Arribas
2
Affiliations
1
Section for Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway. Electronic address: marius.troseid@medisin.uio.no.
2
Infectious Diseases Unit, Internal Medicine Service, IdiPAZ, CIBERINFEC, Madrid, Spain.
PMID:
36641054
PMCID:
PMC9834114
DOI:
10.1016/j.cmi.2023.01.006
No abstract available
Keywords:
COVID-19; Elderly; Fragile; Neglected; Randomized controlled trial.
Publication types
Randomized Controlled Trial
MeSH terms
Aged
COVID-19* / prevention & control
Humans
SARS-CoV-2